Ebrasodebart Biosimilar - Research Grade

Human

TMEM219ï؟½

5mg/ml

IgG4 - lambda2

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Q86XT9

Blue ice

TMEM219 is the cell-surface death receptor for IGFBP3, contributing to apoptotic signaling that is investigated across intestinal and metabolic disease research. This research-grade anti-human TMEM219 recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of ebrasodebart, offered strictly for research use only (RUO). Manufactured to demanding in vivo standards, the low-endotoxin, highly purified formulation is supplied in scalable milligram (mg) to gram (g) quantities to serve heavy-usage, high-throughput laboratories. It functions as a dependable control and active reagent for receptor-blocking assays, in vitro screening, and in vivo disease models exploring epithelial homeostasis.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks